Medical Care
Global Clinical Next-Generation Sequencing Market Research Report 2025
- Sep 18, 25
- ID: 507965
- Pages: 74
- Figures: 77
- Views: 19
This report aims to provide a comprehensive presentation of the global market for Clinical Next-Generation Sequencing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Clinical Next-Generation Sequencing.
The Clinical Next-Generation Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Next-Generation Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Next-Generation Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
PerkinElmer
Illumina
Beckman Coulter
GATC Biotech
Qiagen
Segment by Type
Targeted Sequencing
Exome Sequencing
Others
Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Next-Generation Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Clinical Next-Generation Sequencing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Clinical Next-Generation Sequencing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Clinical Next-Generation Sequencing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher Scientific
PerkinElmer
Illumina
Beckman Coulter
GATC Biotech
Qiagen
Segment by Type
Targeted Sequencing
Exome Sequencing
Others
Segment by Application
Hospitals and Clinics
Biopharma Companies
Academic and Research Organizations
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Clinical Next-Generation Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Next-Generation Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Targeted Sequencing
1.2.3 Exome Sequencing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Clinical Next-Generation Sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Next-Generation Sequencing Market Perspective (2020-2031)
2.2 Global Clinical Next-Generation Sequencing Growth Trends by Region
2.2.1 Global Clinical Next-Generation Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Next-Generation Sequencing Historic Market Size by Region (2020-2025)
2.2.3 Clinical Next-Generation Sequencing Forecasted Market Size by Region (2026-2031)
2.3 Clinical Next-Generation Sequencing Market Dynamics
2.3.1 Clinical Next-Generation Sequencing Industry Trends
2.3.2 Clinical Next-Generation Sequencing Market Drivers
2.3.3 Clinical Next-Generation Sequencing Market Challenges
2.3.4 Clinical Next-Generation Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Next-Generation Sequencing Players by Revenue
3.1.1 Global Top Clinical Next-Generation Sequencing Players by Revenue (2020-2025)
3.1.2 Global Clinical Next-Generation Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Clinical Next-Generation Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Next-Generation Sequencing Revenue
3.4 Global Clinical Next-Generation Sequencing Market Concentration Ratio
3.4.1 Global Clinical Next-Generation Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Next-Generation Sequencing Revenue in 2024
3.5 Global Key Players of Clinical Next-Generation Sequencing Head office and Area Served
3.6 Global Key Players of Clinical Next-Generation Sequencing, Product and Application
3.7 Global Key Players of Clinical Next-Generation Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Next-Generation Sequencing Breakdown Data by Type
4.1 Global Clinical Next-Generation Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Clinical Next-Generation Sequencing Forecasted Market Size by Type (2026-2031)
5 Clinical Next-Generation Sequencing Breakdown Data by Application
5.1 Global Clinical Next-Generation Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Clinical Next-Generation Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Next-Generation Sequencing Market Size (2020-2031)
6.2 North America Clinical Next-Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Clinical Next-Generation Sequencing Market Size by Country (2020-2025)
6.4 North America Clinical Next-Generation Sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Next-Generation Sequencing Market Size (2020-2031)
7.2 Europe Clinical Next-Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Clinical Next-Generation Sequencing Market Size by Country (2020-2025)
7.4 Europe Clinical Next-Generation Sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Next-Generation Sequencing Market Size (2020-2031)
8.2 Asia-Pacific Clinical Next-Generation Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Next-Generation Sequencing Market Size (2020-2031)
9.2 Latin America Clinical Next-Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Clinical Next-Generation Sequencing Market Size by Country (2020-2025)
9.4 Latin America Clinical Next-Generation Sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Next-Generation Sequencing Market Size (2020-2031)
10.2 Middle East & Africa Clinical Next-Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Clinical Next-Generation Sequencing Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Clinical Next-Generation Sequencing Introduction
11.2.4 PerkinElmer Revenue in Clinical Next-Generation Sequencing Business (2020-2025)
11.2.5 PerkinElmer Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Clinical Next-Generation Sequencing Introduction
11.3.4 Illumina Revenue in Clinical Next-Generation Sequencing Business (2020-2025)
11.3.5 Illumina Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Clinical Next-Generation Sequencing Introduction
11.4.4 Beckman Coulter Revenue in Clinical Next-Generation Sequencing Business (2020-2025)
11.4.5 Beckman Coulter Recent Development
11.5 GATC Biotech
11.5.1 GATC Biotech Company Details
11.5.2 GATC Biotech Business Overview
11.5.3 GATC Biotech Clinical Next-Generation Sequencing Introduction
11.5.4 GATC Biotech Revenue in Clinical Next-Generation Sequencing Business (2020-2025)
11.5.5 GATC Biotech Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Clinical Next-Generation Sequencing Introduction
11.6.4 Qiagen Revenue in Clinical Next-Generation Sequencing Business (2020-2025)
11.6.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Next-Generation Sequencing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Targeted Sequencing
1.2.3 Exome Sequencing
1.2.4 Others
1.3 Market by Application
1.3.1 Global Clinical Next-Generation Sequencing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic and Research Organizations
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Clinical Next-Generation Sequencing Market Perspective (2020-2031)
2.2 Global Clinical Next-Generation Sequencing Growth Trends by Region
2.2.1 Global Clinical Next-Generation Sequencing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Clinical Next-Generation Sequencing Historic Market Size by Region (2020-2025)
2.2.3 Clinical Next-Generation Sequencing Forecasted Market Size by Region (2026-2031)
2.3 Clinical Next-Generation Sequencing Market Dynamics
2.3.1 Clinical Next-Generation Sequencing Industry Trends
2.3.2 Clinical Next-Generation Sequencing Market Drivers
2.3.3 Clinical Next-Generation Sequencing Market Challenges
2.3.4 Clinical Next-Generation Sequencing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Next-Generation Sequencing Players by Revenue
3.1.1 Global Top Clinical Next-Generation Sequencing Players by Revenue (2020-2025)
3.1.2 Global Clinical Next-Generation Sequencing Revenue Market Share by Players (2020-2025)
3.2 Global Clinical Next-Generation Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Clinical Next-Generation Sequencing Revenue
3.4 Global Clinical Next-Generation Sequencing Market Concentration Ratio
3.4.1 Global Clinical Next-Generation Sequencing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Next-Generation Sequencing Revenue in 2024
3.5 Global Key Players of Clinical Next-Generation Sequencing Head office and Area Served
3.6 Global Key Players of Clinical Next-Generation Sequencing, Product and Application
3.7 Global Key Players of Clinical Next-Generation Sequencing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Clinical Next-Generation Sequencing Breakdown Data by Type
4.1 Global Clinical Next-Generation Sequencing Historic Market Size by Type (2020-2025)
4.2 Global Clinical Next-Generation Sequencing Forecasted Market Size by Type (2026-2031)
5 Clinical Next-Generation Sequencing Breakdown Data by Application
5.1 Global Clinical Next-Generation Sequencing Historic Market Size by Application (2020-2025)
5.2 Global Clinical Next-Generation Sequencing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Clinical Next-Generation Sequencing Market Size (2020-2031)
6.2 North America Clinical Next-Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Clinical Next-Generation Sequencing Market Size by Country (2020-2025)
6.4 North America Clinical Next-Generation Sequencing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Next-Generation Sequencing Market Size (2020-2031)
7.2 Europe Clinical Next-Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Clinical Next-Generation Sequencing Market Size by Country (2020-2025)
7.4 Europe Clinical Next-Generation Sequencing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Clinical Next-Generation Sequencing Market Size (2020-2031)
8.2 Asia-Pacific Clinical Next-Generation Sequencing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region (2020-2025)
8.4 Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Clinical Next-Generation Sequencing Market Size (2020-2031)
9.2 Latin America Clinical Next-Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Clinical Next-Generation Sequencing Market Size by Country (2020-2025)
9.4 Latin America Clinical Next-Generation Sequencing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Next-Generation Sequencing Market Size (2020-2031)
10.2 Middle East & Africa Clinical Next-Generation Sequencing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country (2020-2025)
10.4 Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Clinical Next-Generation Sequencing Introduction
11.1.4 Thermo Fisher Scientific Revenue in Clinical Next-Generation Sequencing Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 PerkinElmer
11.2.1 PerkinElmer Company Details
11.2.2 PerkinElmer Business Overview
11.2.3 PerkinElmer Clinical Next-Generation Sequencing Introduction
11.2.4 PerkinElmer Revenue in Clinical Next-Generation Sequencing Business (2020-2025)
11.2.5 PerkinElmer Recent Development
11.3 Illumina
11.3.1 Illumina Company Details
11.3.2 Illumina Business Overview
11.3.3 Illumina Clinical Next-Generation Sequencing Introduction
11.3.4 Illumina Revenue in Clinical Next-Generation Sequencing Business (2020-2025)
11.3.5 Illumina Recent Development
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Details
11.4.2 Beckman Coulter Business Overview
11.4.3 Beckman Coulter Clinical Next-Generation Sequencing Introduction
11.4.4 Beckman Coulter Revenue in Clinical Next-Generation Sequencing Business (2020-2025)
11.4.5 Beckman Coulter Recent Development
11.5 GATC Biotech
11.5.1 GATC Biotech Company Details
11.5.2 GATC Biotech Business Overview
11.5.3 GATC Biotech Clinical Next-Generation Sequencing Introduction
11.5.4 GATC Biotech Revenue in Clinical Next-Generation Sequencing Business (2020-2025)
11.5.5 GATC Biotech Recent Development
11.6 Qiagen
11.6.1 Qiagen Company Details
11.6.2 Qiagen Business Overview
11.6.3 Qiagen Clinical Next-Generation Sequencing Introduction
11.6.4 Qiagen Revenue in Clinical Next-Generation Sequencing Business (2020-2025)
11.6.5 Qiagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Clinical Next-Generation Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Targeted Sequencing
Table 3. Key Players of Exome Sequencing
Table 4. Key Players of Others
Table 5. Global Clinical Next-Generation Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Clinical Next-Generation Sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Clinical Next-Generation Sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Clinical Next-Generation Sequencing Market Share by Region (2020-2025)
Table 9. Global Clinical Next-Generation Sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Clinical Next-Generation Sequencing Market Share by Region (2026-2031)
Table 11. Clinical Next-Generation Sequencing Market Trends
Table 12. Clinical Next-Generation Sequencing Market Drivers
Table 13. Clinical Next-Generation Sequencing Market Challenges
Table 14. Clinical Next-Generation Sequencing Market Restraints
Table 15. Global Clinical Next-Generation Sequencing Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Clinical Next-Generation Sequencing Market Share by Players (2020-2025)
Table 17. Global Top Clinical Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Next-Generation Sequencing as of 2024)
Table 18. Ranking of Global Top Clinical Next-Generation Sequencing Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Clinical Next-Generation Sequencing Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Clinical Next-Generation Sequencing, Headquarters and Area Served
Table 21. Global Key Players of Clinical Next-Generation Sequencing, Product and Application
Table 22. Global Key Players of Clinical Next-Generation Sequencing, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Clinical Next-Generation Sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Clinical Next-Generation Sequencing Revenue Market Share by Type (2020-2025)
Table 26. Global Clinical Next-Generation Sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Clinical Next-Generation Sequencing Revenue Market Share by Type (2026-2031)
Table 28. Global Clinical Next-Generation Sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Clinical Next-Generation Sequencing Revenue Market Share by Application (2020-2025)
Table 30. Global Clinical Next-Generation Sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Clinical Next-Generation Sequencing Revenue Market Share by Application (2026-2031)
Table 32. North America Clinical Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Clinical Next-Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Clinical Next-Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Clinical Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Clinical Next-Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Clinical Next-Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Clinical Next-Generation Sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Clinical Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Clinical Next-Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Clinical Next-Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Clinical Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Details
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Clinical Next-Generation Sequencing Product
Table 50. Thermo Fisher Scientific Revenue in Clinical Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. PerkinElmer Company Details
Table 53. PerkinElmer Business Overview
Table 54. PerkinElmer Clinical Next-Generation Sequencing Product
Table 55. PerkinElmer Revenue in Clinical Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 56. PerkinElmer Recent Development
Table 57. Illumina Company Details
Table 58. Illumina Business Overview
Table 59. Illumina Clinical Next-Generation Sequencing Product
Table 60. Illumina Revenue in Clinical Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 61. Illumina Recent Development
Table 62. Beckman Coulter Company Details
Table 63. Beckman Coulter Business Overview
Table 64. Beckman Coulter Clinical Next-Generation Sequencing Product
Table 65. Beckman Coulter Revenue in Clinical Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 66. Beckman Coulter Recent Development
Table 67. GATC Biotech Company Details
Table 68. GATC Biotech Business Overview
Table 69. GATC Biotech Clinical Next-Generation Sequencing Product
Table 70. GATC Biotech Revenue in Clinical Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 71. GATC Biotech Recent Development
Table 72. Qiagen Company Details
Table 73. Qiagen Business Overview
Table 74. Qiagen Clinical Next-Generation Sequencing Product
Table 75. Qiagen Revenue in Clinical Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 76. Qiagen Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
Table 80. Authors List of This Report
List of Figures
Figure 1. Clinical Next-Generation Sequencing Picture
Figure 2. Global Clinical Next-Generation Sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Clinical Next-Generation Sequencing Market Share by Type: 2024 VS 2031
Figure 4. Targeted Sequencing Features
Figure 5. Exome Sequencing Features
Figure 6. Others Features
Figure 7. Global Clinical Next-Generation Sequencing Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Clinical Next-Generation Sequencing Market Share by Application: 2024 VS 2031
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Biopharma Companies Case Studies
Figure 11. Academic and Research Organizations Case Studies
Figure 12. Others Case Studies
Figure 13. Clinical Next-Generation Sequencing Report Years Considered
Figure 14. Global Clinical Next-Generation Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Clinical Next-Generation Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Clinical Next-Generation Sequencing Market Share by Region: 2024 VS 2031
Figure 17. Global Clinical Next-Generation Sequencing Market Share by Players in 2024
Figure 18. Global Top Clinical Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Next-Generation Sequencing as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Clinical Next-Generation Sequencing Revenue in 2024
Figure 20. North America Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Clinical Next-Generation Sequencing Market Share by Country (2020-2031)
Figure 22. United States Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Clinical Next-Generation Sequencing Market Share by Country (2020-2031)
Figure 26. Germany Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Clinical Next-Generation Sequencing Market Share by Region (2020-2031)
Figure 34. China Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Clinical Next-Generation Sequencing Market Share by Country (2020-2031)
Figure 42. Mexico Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Clinical Next-Generation Sequencing Market Share by Country (2020-2031)
Figure 46. Turkey Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2020-2025)
Figure 50. PerkinElmer Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2020-2025)
Figure 51. Illumina Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2020-2025)
Figure 52. Beckman Coulter Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2020-2025)
Figure 53. GATC Biotech Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2020-2025)
Figure 54. Qiagen Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Table 1. Global Clinical Next-Generation Sequencing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Targeted Sequencing
Table 3. Key Players of Exome Sequencing
Table 4. Key Players of Others
Table 5. Global Clinical Next-Generation Sequencing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Clinical Next-Generation Sequencing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Clinical Next-Generation Sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Clinical Next-Generation Sequencing Market Share by Region (2020-2025)
Table 9. Global Clinical Next-Generation Sequencing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Clinical Next-Generation Sequencing Market Share by Region (2026-2031)
Table 11. Clinical Next-Generation Sequencing Market Trends
Table 12. Clinical Next-Generation Sequencing Market Drivers
Table 13. Clinical Next-Generation Sequencing Market Challenges
Table 14. Clinical Next-Generation Sequencing Market Restraints
Table 15. Global Clinical Next-Generation Sequencing Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Clinical Next-Generation Sequencing Market Share by Players (2020-2025)
Table 17. Global Top Clinical Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Next-Generation Sequencing as of 2024)
Table 18. Ranking of Global Top Clinical Next-Generation Sequencing Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Clinical Next-Generation Sequencing Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Clinical Next-Generation Sequencing, Headquarters and Area Served
Table 21. Global Key Players of Clinical Next-Generation Sequencing, Product and Application
Table 22. Global Key Players of Clinical Next-Generation Sequencing, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Clinical Next-Generation Sequencing Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Clinical Next-Generation Sequencing Revenue Market Share by Type (2020-2025)
Table 26. Global Clinical Next-Generation Sequencing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Clinical Next-Generation Sequencing Revenue Market Share by Type (2026-2031)
Table 28. Global Clinical Next-Generation Sequencing Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Clinical Next-Generation Sequencing Revenue Market Share by Application (2020-2025)
Table 30. Global Clinical Next-Generation Sequencing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Clinical Next-Generation Sequencing Revenue Market Share by Application (2026-2031)
Table 32. North America Clinical Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Clinical Next-Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Clinical Next-Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Clinical Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Clinical Next-Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Clinical Next-Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Clinical Next-Generation Sequencing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Clinical Next-Generation Sequencing Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Clinical Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Clinical Next-Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Clinical Next-Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Clinical Next-Generation Sequencing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Clinical Next-Generation Sequencing Market Size by Country (2026-2031) & (US$ Million)
Table 47. Thermo Fisher Scientific Company Details
Table 48. Thermo Fisher Scientific Business Overview
Table 49. Thermo Fisher Scientific Clinical Next-Generation Sequencing Product
Table 50. Thermo Fisher Scientific Revenue in Clinical Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 51. Thermo Fisher Scientific Recent Development
Table 52. PerkinElmer Company Details
Table 53. PerkinElmer Business Overview
Table 54. PerkinElmer Clinical Next-Generation Sequencing Product
Table 55. PerkinElmer Revenue in Clinical Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 56. PerkinElmer Recent Development
Table 57. Illumina Company Details
Table 58. Illumina Business Overview
Table 59. Illumina Clinical Next-Generation Sequencing Product
Table 60. Illumina Revenue in Clinical Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 61. Illumina Recent Development
Table 62. Beckman Coulter Company Details
Table 63. Beckman Coulter Business Overview
Table 64. Beckman Coulter Clinical Next-Generation Sequencing Product
Table 65. Beckman Coulter Revenue in Clinical Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 66. Beckman Coulter Recent Development
Table 67. GATC Biotech Company Details
Table 68. GATC Biotech Business Overview
Table 69. GATC Biotech Clinical Next-Generation Sequencing Product
Table 70. GATC Biotech Revenue in Clinical Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 71. GATC Biotech Recent Development
Table 72. Qiagen Company Details
Table 73. Qiagen Business Overview
Table 74. Qiagen Clinical Next-Generation Sequencing Product
Table 75. Qiagen Revenue in Clinical Next-Generation Sequencing Business (2020-2025) & (US$ Million)
Table 76. Qiagen Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
Table 80. Authors List of This Report
List of Figures
Figure 1. Clinical Next-Generation Sequencing Picture
Figure 2. Global Clinical Next-Generation Sequencing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Clinical Next-Generation Sequencing Market Share by Type: 2024 VS 2031
Figure 4. Targeted Sequencing Features
Figure 5. Exome Sequencing Features
Figure 6. Others Features
Figure 7. Global Clinical Next-Generation Sequencing Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Clinical Next-Generation Sequencing Market Share by Application: 2024 VS 2031
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Biopharma Companies Case Studies
Figure 11. Academic and Research Organizations Case Studies
Figure 12. Others Case Studies
Figure 13. Clinical Next-Generation Sequencing Report Years Considered
Figure 14. Global Clinical Next-Generation Sequencing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Clinical Next-Generation Sequencing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Clinical Next-Generation Sequencing Market Share by Region: 2024 VS 2031
Figure 17. Global Clinical Next-Generation Sequencing Market Share by Players in 2024
Figure 18. Global Top Clinical Next-Generation Sequencing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Clinical Next-Generation Sequencing as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Clinical Next-Generation Sequencing Revenue in 2024
Figure 20. North America Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Clinical Next-Generation Sequencing Market Share by Country (2020-2031)
Figure 22. United States Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Clinical Next-Generation Sequencing Market Share by Country (2020-2031)
Figure 26. Germany Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Clinical Next-Generation Sequencing Market Share by Region (2020-2031)
Figure 34. China Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Clinical Next-Generation Sequencing Market Share by Country (2020-2031)
Figure 42. Mexico Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Clinical Next-Generation Sequencing Market Share by Country (2020-2031)
Figure 46. Turkey Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Clinical Next-Generation Sequencing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2020-2025)
Figure 50. PerkinElmer Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2020-2025)
Figure 51. Illumina Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2020-2025)
Figure 52. Beckman Coulter Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2020-2025)
Figure 53. GATC Biotech Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2020-2025)
Figure 54. Qiagen Revenue Growth Rate in Clinical Next-Generation Sequencing Business (2020-2025)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232